Natural product-derived therapy for glucose homeostasis and TIIDM: Rice bran protein hydrolysates (RBPs) increase Pax6 and insulin expression, decrease the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improve insulin sensitivity, promote glucose homeostasis and prevents progression to TIIDM via down regulation of their target gene, 10/February/2017, 11.22 pm

Natural product-derived therapy for Metastatic human tumors: Magnolin, one of the main components of herb Magnolia fargesii/Flos, decreases the expression of c-Src protein, inhibits the expression of a number of enzymes in glycolytic cycle, and suppresses proliferation, migration, invasion, tumorigenesis and metastasis via up regulation of its target gene, 10/February/2017, 10.55 pm
February 10, 2017
Anti-telomerase cancer therapy: Calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali, suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene, 11/February/2017, 5.58 am
February 11, 2017
Show all

Introduction: What they say 

A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel shows that “PAX6 maintains ß cell identity by repressing genes of alternative islet cell types.” This research paper was published in the 12 December 2016 issue of the journal “Journal of Clinical investigations” [One of the best research journals in Clinical Medicine with an I.F of 12.575] by Prof. Yuval Dor and Avital Swisa and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for glucose homeostasis and TIIDM: Rice bran protein hydrolysates (RBPs) increase Pax6 and insulin expression, decrease the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improve insulin sensitivity, promote glucose homeostasis and prevents progression to TIIDM via down regulation of their target gene


From Significance of the study to Public health relevance:

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

Prof. Yuval Dor’s research team has recently shown that deletion of Pax6 in mice results in: (1) Hyperglycemia; (2) Ketosis (higher levels of 3-hydroxybutyrate and acetoacetate); (3) down regulation of Mafa, Insulin, Nkx6.1, Pdx1, Isl1, Foxa2, Slc2a2 (GLUT2), G6pc2, and Slc30a8; (4) up regulation of glucagon, somatostatin, ghrelin, Neurog, gastrin, and pancreatic polypeptide; (5) loss of ß cell differentiation and function; and (6) expansion of α-cells.

Further, they have shown that: (1) Pax6 increases the expression of insulin; (2) Pax6 decreases the expression of islet cell genes, such as ghrelin, glucagon, somatostatin, FOXA2, and Neurog3; (3) Pax6 is down regulated in ß cell of diabetic mice; and (4) Pax6’s function is preserved in pancreatic ß cells of human, suggesting that increasing the expression of Pax6 in diabetic patients may alleviate TIIDM.


From Research findings to Therapeutic opportunity:

Rice bran protein hydrolysates (RBPs)by increasing the expression of their target gene, they may increase the expression of Pax6 (fig.1).

Rice bran induces pax6 expression

Figure 1. Mechanistic insights into how Rice bran protein hydrolysates (RBPs) functions as an anti-hyperglycemic agent.  Rice bran protein hydrolysates (RBPs) may prevent progression to TIIDM via up regulation of Pax6 and insulin; and down regulation of glucagon, ghrelin and Somatostatin

price-300[easy_payment currency=”USD”]

Thereby, they may: (1) increase insulin sensitivity; (2) inhibit the expression of islet cell genes, including glucagon, ghrelin and Somatostatin; (3) increase the expression of Mafa, Insulin, Nkx6.1, Pdx1, Isl1, Foxa2; (4) decrease metabolic stress; and (5) promote glucose homeostasis (Figs.1-3). Thus, pharmacological formulations encompassing Rice bran protein hydrolysates (RBPs)  or an active compound isolated from them or Rice bran protein hydrolysates (RBPs) in combination with other natural products/drugs” may be used to treat TIIDM.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How Rice bran protein hydrolysates (RBPs) increase the expression of Pax6 to promote insulin sensitivity

Amount: $300

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L., Natural product-derived therapy for glucose homeostasis and TIIDM: Rice bran protein hydrolysates (RBPs) increase Pax6 and insulin expression, decrease the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improve insulin sensitivity, promote glucose homeostasis and prevents progression to TIIDM via down regulation of their target gene, 10/February/2017, 11.22 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.